bioRxivNeurosciencePreprint
Spatial Bias in Lesion Network Mapping Is Connectome-Independent
Max WawrzyniakiD, Tim RitteriD, Julian KlingbeiliD, Gordian PrasseiD, Dorothee SauriD, Anika StockertiD
Abstract
Lesion network mapping (LNM) is increasingly used to link focal brain lesions to distributed functional networks. Recent work has raised concerns that LNM results may be spatially biased by dominant features of the normative connectome. If this were the case, three testable predictions would follow: (i) a consistent spatial pattern of false positives across LNM studies, (ii) that this pattern can be consistently explained by intrinsic connectome organization, and (iii) that symptom-associated LNM findings preferentially occur in regions with high spatial bias. We tested these predictions across three independent LNM datasets (n = 49/101/200), evaluating each prediction in all cohorts. Spatial bias maps derived from 4,000,000 random permutations under the null hypothesis showed minimal correspondence across cohorts (R2 = 0.4-0.8%), indicating strong cohort specificity. Moreover, dominant connectome features--captured by the first 10 principal components of connectivity profiles from 1,000 atlas regions--did not systematically explain these bias maps. Finally, symptom-associated results showed no enrichment in high-bias regions. Together, these findings provide strong evidence that spatial bias in LNM is not driven by dominant connectome features. With appropriate inferential statistics and rigorous study design, LNM remains a valid approach for mapping symptom-related brain networks.
- organism: human
- assay: spatial transcriptomics
- research focus: benchmarking
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Robust lesion network mapping reveals symptom-specific circuits
Weigang Cui, Jiayi Zhu, … Hesheng Liu·bioRxiv·May 19, 2026
- The diversity of lesion network mapping findings
Yao Meng, Wenqiang Xu, … Gong‐Jun Ji·bioRxiv·Feb 16, 2026
- The methodological foundations of lesion network mapping remain sound
Shan Siddiqi, Andreas Horn, … Michael Fox·bioRxiv·Feb 26, 2026
- Evaluating the value and limits of null-models for Lesion Network Mapping
Martijn P. van den Heuvel, Ilan Libedinsky, … Luca Cocchi·bioRxiv·Sep 29, 2026
- Connectome Principal Component Drives Cross-Dataset Replication and Clinical Prediction in Symptom Lesion Network Mapping
Sasin Treeratana, Arp‐Arpa Kasemsantitham, … Chaipat Chunharas·bioRxiv·Jun 4, 2026
- Assessing specificity testing in Lesion Network Mapping
Martijn P. van den Heuvel, Ilan Libedinsky, … Luca Cocchi·bioRxiv·Sep 1, 2026